T2D is a metabolic disorder driven by polygenes and environmental risk factors, which is characterized by impaired insulin secretion arising from progressive pancreatic β-cell dysfunction and loss of β-cell mass and insulin resistance in the target peripheral tissues, resulting in multiple long-term health complications (3–5). This evidence concerns the gene INS and Insulin resistance.